Description of Research Expertise
Dr. Michael J. LaRiviere is an attending radiation oncologist at the Children's Hospital of Philadelphia and the University of Pennsylvania. He did his undergraduate work in neuroscience at Amherst College, medical school at Emory University, and residency at the University of Pennsylvania. He treats pediatric patients and adult patients with hematologic malignancies, using conventional photon radiotherapy, stereotactic body radiotherapy, proton therapy, reirradiation, total skin electron therapy, and total body irradiation. Dr. LaRiviere leads research programs in translational pediatric and hematologic radiation oncology, including preclinical work with FLASH radiotherapy and clinical trials to understand the interactions between immunotherapy and radiation, and chimeric antigen T-cell (CART) therapy and radiation. Dr. LaRiviere has received research funding from the Radiological Society of North America to explore how 3D-printing can be used to improve oncology education for medical students. He is a member of the Children's Oncology Group (COG), International Society of Paediatric Oncology (Société Internationale d'Oncologie Pédiatrique - SIOP), Paediatric Radiation Oncology Society (PROS), International Lymphoma Radiation Oncology Group (ILROG), and University of Pennsylvania Radiation Oncology Quality Assurance/Quality Improvement Committee.
Selected Publications
Matous, Allison, Jarvis, Lesley, LaRiviere, Michael: A Review of Follicular Lymphoma in 4 Cases American Society for Radiation Oncology : 2024.
Zhu, Timothy C, Zhu, Yifeng, Byrd, Brook Kennedy, Lu, Baozhu, Alexander, Daniel A, LaRiviere, Michael, Plastaras, John: Can Simple Analytical Algorithm Predict Dose Distribution for Total Skin Electron Therapy (TSET)? AAPM Annual Meeting 2024, Los Angeles, CA : 2024.
Zhu, Yifeng, Byrd, Brook, Alexander, Daniel, Maity, Amit, Plastaras, John P, LaRiviere, Michael, Pogue, Brian W, Zhu, Timothy C: Validation of the Cherenkov converted dose using multiple Cherenkov images on TSET patients Society of Photo-Optical Instrumentation Engineers (SPIE) Photonic West, San Franciso, CA : PC1282302,2024.
Baron JA, Wright CM, Dreyfuss AD, Chong EA, Svoboda J, LaRiviere MJ, Jones JA, Maity A, Plastaras JP, Paydar I, Maxwell R: Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell Lymphoma Practical Radiation Oncology 14 (5): e362-e372,2024.
Chelius, Monica, Cohen, Leah, Mallon, John, Rook, Alain, Villasenor-Park, Jennifer, Samimi, Sara, Kim, Ellen, Plastaras, John, Barta, Stefan, Lariviere, Michael: 52332 Safety of Total Skin Electron Therapy with Concurrent Systemic Therapy Journal of the American Academy of Dermatology 91 (3): AB308,2024.
Dreyfuss, Alexandra, Ganesan, Nivetha, Alencar, Alvaro J, Boardman, Alexander P, Caron, Philip, Chang, Tiffany, Davey, Theresa, David, Kevin A, Dogan, Ahmet, Epstein-Peterson, Zachary D: Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study Blood 144 : 4434,2024.
Elghawy, Omar, Sussman, Jonathan, Yang, Austin, Thomas, Colin J, Carter, Jordan S, Landsburg, Daniel J, Svoboda, Jakub, Kim, Ellen, Rook, Alain, Chung, Jina: Single Institution Experience of Pembrolizumab for Patients with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome SOHO 2024 Annual Meeting 5 : 16.7,2024.
Elghawy, Omar, Thomas, Colin J, Carter, Jordan S, Landsburg, Daniel J, Svoboda, Jakub, Kim, Ellen, Rook, Alain, Chung, Jina, Plastaras, John P, LaRiviere, Michael: TCL-320 Single Institution Experience of Pembrolizumab for Patients with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome Clinical Lymphoma Myeloma and Leukemia 24 : S522,2024.
Elghawy O, Yang AG, Sussman JH, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Villasenor-Park J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK: Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome Journal of the American Academy of Dermatology S0190-9622 (24): 03212-2,2024.
Jiang C, Kim M, Han X, Chelius M, Hoover T, Kersun L, Reilly AF, Hubbeling H, Cummings E, Kurtz G, Hill-Kayser C, Plastaras JP, LaRiviere MJ: Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphoma Pediatric Blood & Cancer 71 (12): e31290,2024.
View all publications
Academic Contact Information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd., PCAM 2 West
Philadelphia,
PA
19104
Phone: 215-615-7239
Patient appointments: 800-789-7366